January 21, 2020 / 6:18 AM / a month ago

BRIEF-Cosmo Pharmaceuticals Aligns With FDA On Methylene Blue MMX Second Phase III Study

Jan 21 (Reuters) - COSMO PHARMACEUTICALS NV:

* METHYLENE BLUE MMX REGULATORY UPDATE: SUBSTANTIAL ALIGNMENT REACHED WITH FDA ON SECOND PHASE III STUDY FEATURES - NEXT STEPS

* NEXT STEP IS SUBMISSION OF PROTOCOL AND PLAN (EXPECTED IN Q1 2020) FOR FINAL COMMENT BY FDA BEFORE TRIAL PLANNED IN H1 2020 Source text for Eikon: Further company coverage: (Gdansk Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below